Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Elon Musk
Apple
OnePlus
NOTHING
Latest Laptops
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / India will start COVID-19 vaccine production next month: Details here
Technology

India will start COVID-19 vaccine production next month: Details here

India will start COVID-19 vaccine production next month: Details here
Written by Shubham Sharma
Apr 26, 2020, 06:08 pm 3 min read
India will start COVID-19 vaccine production next month: Details here

In a major development, Cyrus S. Poonawalla's Serum Institute of India has confirmed that it will start making a vaccine for COVID-19 next month. The solution, the institute says, is the candidate vaccine that has been developed by Oxford University researchers and is currently being examined in the human trial phase. Here's all you need to know about it.

Partnership
Partnership with Oxford for vaccine

The vaccine major, according to a PTI report, has partnered with Oxford University for its vaccine and is planning to begin production in a matter of weeks. Adar Poonawalla, the CEO of the institute, said, "Our team has been working closely with Dr. Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 weeks."

Production
5 million doses to be manufactured every month

Detailing the production strategy, the CEO said they plan to manufacture 5 million doses of the vaccine every month for the first six months. After that, the production capacity would be scaled up to 10 million doses to meet the demand for the vaccine. He did not comment on how much people would have to pay for this vaccine.

Caveat
But, all depends on success of human trials

While the step by SII is significant, it is imperative to note that this is a proactive move and the final availability of the vaccine would directly depend on how the trials pan out. If all goes well and the vaccine is confirmed to be effective and safe, we could see it in the market by September-October. Otherwise, there might be some delays.

Quote
India trials will also begin in 2-3 weeks, Poonawalla added

"We expect the (COVID-19) vaccine to be out in the market by September - October, only if the trials are successful with the requisite safety and assured efficacy. We will be starting trials in India for this vaccine hopefully over the next 2-3 weeks' time."

Goal
Risk taken to have vaccine in sufficient quantity

The move to start production ahead of trials' conclusion is aimed at having sufficient doses to fight the pandemic. "We have undertaken the decision to initiate manufacturing at our own risk," the CEO emphasized while noting that they wanted "to have a jump-start on manufacturing, to have enough doses available if the clinical trials prove successful."

Progress
Work proceeding with Indian regulatory authorities

As of now, SII is working with Indian regulatory authorities, including the ICMR and Department of Biotechnology, to get the necessary approvals for the trials and production of the vaccine. Poonawalla says that they also hope to enlist the support of more industry partners to scale up the production of the vaccine and make it more widely available as soon as possible.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Oxford
Oxford University
PTI
Department of Biotechnology
Coronavirus
Related
Latest
Apple AirPods Pro (2nd generation) to feature Type-C port
Apple AirPods Pro (2nd generation) to feature Type-C port Technology
England vs India, 5th Test: Day 4 report and stats
England vs India, 5th Test: Day 4 report and stats Sports
2022 Wimbledon: Simona Halep beats Paula Badosa, reaches quarter-finals
2022 Wimbledon: Simona Halep beats Paula Badosa, reaches quarter-finals Sports
Rohit Sharma vs England: Decoding his stats in white-ball cricket
Rohit Sharma vs England: Decoding his stats in white-ball cricket Sports
Akasa Air boasts new crew uniforms as youthful, eco-friendly
Akasa Air boasts new crew uniforms as youthful, eco-friendly Business
Oxford
Coronavirus vaccine consignment awaits government nod for take-off from Pune
Coronavirus vaccine consignment awaits government nod for take-off from Pune India
All states to hold dry run for coronavirus vaccination today
All states to hold dry run for coronavirus vaccination today India
Coronavirus: India's daily death toll remained under 300 last week
Coronavirus: India's daily death toll remained under 300 last week India
India set to start COVID-19 vaccination; panel approves Oxford vaccine
India set to start COVID-19 vaccination; panel approves Oxford vaccine India
India could approve coronavirus vaccine soon, key meeting today
India could approve coronavirus vaccine soon, key meeting today India
More News
Oxford University
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll World
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
AstraZeneca vaccine's single dose reduces death risk by 80%: Data World
#OxfordUniversity racism row: India to raise the issue when required
#OxfordUniversity racism row: India to raise the issue when required India
Five killed in Serum Institute fire; Maharashtra government orders probe
Five killed in Serum Institute fire; Maharashtra government orders probe India
Maldives to become first foreign country to receive Covishield doses
Maldives to become first foreign country to receive Covishield doses World
More News
PTI
Islamabad on high alert after rumors of Imran Khan's assassination
Islamabad on high alert after rumors of Imran Khan's assassination World
No-confidence motion tabled against Pakistan PM Imran Khan
No-confidence motion tabled against Pakistan PM Imran Khan World
Pakistan: No-confidence vote against PM Imran Khan likely today
Pakistan: No-confidence vote against PM Imran Khan likely today World
Farmers' protest: Mobile internet services suspended in 14 Haryana districts
Farmers' protest: Mobile internet services suspended in 14 Haryana districts India
Parliament canteen's subsidy ends; non-veg buffet now costs Rs. 700
Parliament canteen's subsidy ends; non-veg buffet now costs Rs. 700 Politics
More News
Department of Biotechnology
Mumbai's Tata Memorial Hospital conducts India's first CAR-T cell therapy
Mumbai's Tata Memorial Hospital conducts India's first CAR-T cell therapy Technology
India's neighbors train experts for clinical trials of COVID-19 vaccine
India's neighbors train experts for clinical trials of COVID-19 vaccine India
Sputnik V phase 3 trials could be conducted in India
Sputnik V phase 3 trials could be conducted in India India
IIT-H should remain relevant to 4th industrial revolution: President Kovind
IIT-H should remain relevant to 4th industrial revolution: President Kovind India
Government to set up DNA databanks at national, state level
Government to set up DNA databanks at national, state level India
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
Related
COVID-19: Serum to start producing Sputnik V vaccine from September
COVID-19: Serum to start producing Sputnik V vaccine from September India
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022